Bulletin: France-Based VINCI S.A. Ratings Unchanged After Recent Acquisitions Jun 07

  • ID: 2042997
  • June 2007
  • Standard & Poors
1 of 3

PARIS (Standard & Poor's) June 4, 2007--Standard & Poor's Ratings Services said today that the ratings on French concession and construction group VINCI S.A. (BBB+/Negative/A-2) remain unchanged after the group's May 31, 2007, announcement that it will acquire Entrepose Contracting, an oil and gas engineering and construction company. This deal closely follows the purchase of nuclear decommissioning specialist Nukem Ltd. Following these acquisitions, VINCI's credit ratios will weaken slightly in 2007 versus 2006, despite an expected strong 2007 operating performance. We still expect the company to strengthen adjusted funds from operations (FFO) to net debt to close to 20% and adjusted FFO to net interest to a minimum 5.0x in 2010, from 15% and about 4.5x in 2007. We will...

Companies mentioned in this report are: VINCI S.A.
Action: Bulletin

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3


Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.